Profile of inotuzumab ozogamicin and its potential in the treatment of acute lymphoblastic leukemia
Xavier Thomas Hospices Civils de Lyon, Hematology, Lyon-Sud Hospital, Pavillon Marcel Bérard, France Abstract: Monoclonal antibodies are likely to make a considerable contribution in the treatment of acute lymphoblastic leukemia (ALL). High expression of CD22 antigen is found on the sur...
Guardado en:
Autor principal: | Thomas X |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/89abc1d5f8824785adfdca466fa9eea8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A REGISTRY-BASED, OBSERVATIONAL SAFETY STUDY OF INOTUZUMAB OZOGAMICIN (INO) IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PROCEEDING TO HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
por: David MARKS, et al.
Publicado: (2021) -
Emerging treatment approaches in acute lymphoblastic and acute myeloid leukemias
por: Thomas X
Publicado: (2012) -
POST-TREATMENT NUTRITIONAL STATUS OF CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
por: Akbar Akbarov, et al.
Publicado: (2021) -
Therapeutic developments in acute lymphoblastic leukemia
por: MacKenzie A, et al.
Publicado: (2012) -
BONE AS A SITE OF EXTRAMEDULLARY DISEASE IN ACUTE LYMPHOBLASTIC LEUKEMIA
por: Fatma Tuba YILDIRIM, et al.
Publicado: (2021)